Omkar Pharmachem Limited (BOM:532167)

Omkar Pharmachem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	169	297	303	227	252	206
Market Cap Growth	-34.77%	-1.67%	33.45%	-10.08%	22.55%	-1.44%
Enterprise Value	167	297	304	231	259	214
Last Close Price	16.75	29.50	30.00	22.48	25.00	20.40

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	138.67	244.23	150.58	119.88	127.45	112.35
PS Ratio	36.32	63.97	56.02	41.98	46.69	38.10
PB Ratio	0.46	0.81	3.21	2.46	2.79	2.33
P/TBV Ratio	0.46	0.81	3.21	2.46	2.79	2.33
P/FCF Ratio	73.95	130.24	126.31	79.18	91.37	104.96
P/OCF Ratio	73.95	130.24	124.23	76.69	91.37	101.44

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	35.86	63.84	56.25	42.74	47.92	39.69
EV/EBITDA Ratio	103.69	184.62	104.89	81.52	83.24	79.76
EV/EBIT Ratio	105.86	188.49	106.62	82.90	83.97	80.33
EV/FCF Ratio	73.00	129.98	126.83	80.61	93.80	109.34

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	-	-	0.01	0.03	0.07	0.11
Debt / EBITDA Ratio	-	-	0.41	1.07	2.00	3.46
Debt / FCF Ratio	-	-	0.50	1.06	2.25	4.74
Net Debt / Equity Ratio	-0.01	-0.01	0.00	0.03	0.05	0.08
Net Debt / EBITDA Ratio	-1.35	-1.35	0.03	0.82	1.57	2.67
Net Debt / FCF Ratio	-0.95	-0.95	0.04	0.81	1.77	3.67
Asset Turnover	0.02	0.02	0.06	0.06	0.06	0.06
Quick Ratio	4.93	4.93	1.56	0.50	0.26	0.22
Current Ratio	5.96	5.96	1.56	0.51	0.38	0.30
Return on Equity (ROE)	0.53%	0.53%	2.15%	2.07%	2.21%	2.09%
Return on Assets (ROA)	0.43%	0.43%	1.85%	1.80%	1.97%	1.71%
Return on Invested Capital (ROIC)	0.51%	0.51%	2.24%	2.19%	2.41%	2.43%
Return on Capital Employed (ROCE)	0.40%	0.40%	3.00%	3.00%	3.40%	3.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	0.72%	0.41%	0.66%	0.83%	0.78%	0.89%
FCF Yield	1.35%	0.77%	0.79%	1.26%	1.09%	0.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error